Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.

Rubio MT, D'Aveni-Piney M, Labopin M, Hamladji RM, Sanz MA, Blaise D, Ozdogu H, Daguindeau E, Richard C, Santarone S, Irrera G, Yakoub-Agha I, Yeshurun M, Diez-Martin JL, Mohty M, Savani BN, Nagler A

Open source

DOI: 10.1186/s13045-016-0389-4
Published: 2017 Jan 24
Container: Journal of hematology & oncology
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13045-016-0389-4,
  title = {Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.},
  author = {Rubio MT and D'Aveni-Piney M and Labopin M and Hamladji RM and Sanz MA and Blaise D and Ozdogu H and Daguindeau E and Richard C and Santarone S and Irrera G and Yakoub-Agha I and Yeshurun M and Diez-Martin JL and Mohty M and Savani BN and Nagler A},
  year = {2017},
  journal = {Journal of hematology \& oncology},
  doi = {10.1186/s13045-016-0389-4},
  url = {https://doi.org/10.1186/s13045-016-0389-4}
}

RIS

TY  - JOUR
TI  - Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.
AU  - Rubio MT
AU  - D'Aveni-Piney M
AU  - Labopin M
AU  - Hamladji RM
AU  - Sanz MA
AU  - Blaise D
AU  - Ozdogu H
AU  - Daguindeau E
AU  - Richard C
AU  - Santarone S
AU  - Irrera G
AU  - Yakoub-Agha I
AU  - Yeshurun M
AU  - Diez-Martin JL
AU  - Mohty M
AU  - Savani BN
AU  - Nagler A
PY  - 2017
JO  - Journal of hematology & oncology
DO  - 10.1186/s13045-016-0389-4
UR  - https://doi.org/10.1186/s13045-016-0389-4
ER  -

APA

MT, R., M, D., M, L., RM, H., MA, S., D, B., H, O., E, D., C, R., S, S., G, I., I, Y., M, Y., JL, D., M, M., BN, S., & A, N. (2017). Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party.. Journal of hematology & oncology. https://doi.org/10.1186/s13045-016-0389-4

Source records

pubmed · retrieved 2026-09-25T14:50:10.996Z
europe-pmc · retrieved 2026-09-25T14:50:10.995Z
doaj · retrieved 2026-09-25T14:50:11.002Z
hal · retrieved 2026-09-25T14:50:11.053Z